Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Construction method and application of transgenic animal with increased blood-brain barrier permeability

A technology of transgenic animals and drugs, applied in the field of construction of transgenic animal models, can solve problems such as the inability to stably open the blood-brain barrier and restrict the development of drugs in the central nervous system.

Inactive Publication Date: 2016-01-20
GUANGDONG PHARMA UNIV
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0013] Studies have shown that in the treatment of intracranial diseases, focused ultrasound can not only ablate the blood-brain barrier, but also partially open the blood-brain barrier, but it still cannot open the blood-brain barrier stably.
[0014] Although there are many ways to open the blood-brain barrier at present, there are problems in varying degrees, such as safety, targeting, tissue compatibility, etc., which seriously restrict the development of central nervous system drugs.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Construction method and application of transgenic animal with increased blood-brain barrier permeability
  • Construction method and application of transgenic animal with increased blood-brain barrier permeability
  • Construction method and application of transgenic animal with increased blood-brain barrier permeability

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0025] Slit is an extracellular matrix secreted protein. It was discovered in Drosophila by NussleinVolhard et al. in 1984. The encoded gene is 4p15.2. Its main function is to guide the direction and direction of axon formation during the development of the central nervous system. Migration of nerve cells, and participate in the proliferation, apoptosis, adhesion and migration of non-neural cells during the formation of organs. Current studies have confirmed that the Slit protein family in mammals has three subtypes (Slit1, Slit2, Slit3), which share 60% homology. Slit1 is only expressed in nerve tissue; Slit2 is distributed in nerve tissue, kidney, lung and endothelial cells; Slit3 is localized in mitochondria, mainly in lung tissue, and also in kidney, brain, heart, spleen and lymph nodes. The Slit protein consists of an N-terminal signal peptide, four consecutive leucine-rich repeat LRRs, and nine EGF-like functional regions (such as figure 1 ). The LRR repeats are requir...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a construction method and application of a transgenic mouse with increased blood-brain barrier permeability. The method for constructing transgenic engineering mice with increased blood-brain barrier permeability includes modifying the gene to increase the expression of slit protein, and obtaining a transgenic animal model with increased blood-brain barrier permeability. The study found that the overexpression of slit protein caused enlargement of the lateral ventricles of mice, severe damage to the structure of the choroid plexus, and loss of tight junctions of epithelial cells. Observing the vascular structure of the brain of Slit-Tg mice by immunofluorescence staining found that the cerebral vascular bifurcation was less, and the microvessels were more, and the shape of the blood vessels was incomplete and the distribution was irregular. Transmission electron micrographs also showed that the endothelial cells of Slit-Tg mice were damaged, extremely irregular, and the vascular basement membrane was incomplete. Evans? blue? The assay detected the increased permeability of the mice, indicating that the blood-brain barrier permeability of Slit-Tg mice was increased, which can be applied to the animal experiments of central nervous system drugs for the screening, development and efficacy evaluation of neurological drugs.

Description

technical field [0001] The invention relates to a method for constructing a transgenic animal model and its application, in particular to a method for constructing a transgenic animal model with increased permeability of the blood-brain barrier and its application. Background technique [0002] The central nervous system is the most stringent and sensitive system in the human body. Normal neural function requires a highly stringent extracellular environment, where the ion concentrations of sodium, calcium and potassium need to be restricted within a very narrow range. And the metabolic demands of the nervous system are very strong, consuming 20% ​​of the body's oxygen consumption. [0003] The nervous system is very sensitive to many chemical substances. Many substances in the daily diet, although harmless to other organs, are neurotoxic, so there is an interface between the peripheral circulatory system and the central nervous system of mammals , to dynamically adjust ion...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12N15/85G01N33/15
Inventor 王丽京李江超亓翠玲韩露温寅鑫
Owner GUANGDONG PHARMA UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products